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Abstract
Background: Biomedical research is changing due to the rapid accumulation of experimental data at an unprecedented scale,
revealing increasing degrees of complexity of biological processes. Life Sciences are facing a transition from a descriptive to a
mechanistic approach that reveals principles of cells, cellular networks, organs, and their interactions across several spatial and
temporal scales. There are two conceptual traditions in biological computational-modeling. The bottom-up approach
emphasizes complex intracellular molecular models and is well represented within the systems biology community. On the other
hand, the physics-inspired top-down modeling strategy identifies and selects features of (presumably) essential relevance to the
phenomena of interest and combines available data in models of modest complexity.
Results: The workshop, "ESF Exploratory Workshop on Computational disease Modeling", examined the challenges that
computational modeling faces in contributing to the understanding and treatment of complex multi-factorial diseases.
Participants at the meeting agreed on two general conclusions. First, we identified the critical importance of developing analytical
tools for dealing with model and parameter uncertainty. Second, the development of predictive hierarchical models spanning
several scales beyond intracellular molecular networks was identified as a major objective. This contrasts with the current focus
within the systems biology community on complex molecular modeling.
Conclusion: During the workshop it became obvious that diverse scientific modeling cultures (from computational
neuroscience, theory, data-driven machine-learning approaches, agent-based modeling, network modeling and stochastic-
molecular simulations) would benefit from intense cross-talk on shared theoretical issues in order to make progress on clinically
relevant problems.
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The recent "ESF Exploratory Workshop on Computational
disease Modeling" [1] workshop in Barcelona (Sept. 24–
26, 2008) brought together modelers, experimentalists
and clinicians to discuss how multi-factorial human dis-
eases (including multiple sclerosis, cancer, cardiovascular
and kidney diseases, diabetes, sepsis, allergy, schizophre-
nia and addiction) can be modeled given the currently
available knowledge and data. Experts covered areas such
as molecular network modeling, computational neuro-
science, pharmacokinetic and pharmacodynamic mode-
ling, hierarchical modeling and agent-based modeling.
Successful modeling of diseases is greatly facilitated by
standards for data-collection and storage, interoperable
representation, and computational tools enabling pat-
tern/network analysis and modeling. There are several
important initiatives in this direction, such as the ELIXIR
program [2] providing sustainable bioinformatics infra-
structure for biomedical data in Europe. Similar initiatives
are in progress in the USA and Asia. Yet these efforts in
themselves are not sufficient, as the predictive under-
standing of complex diseases requires computational
modeling and representation of these data. However,
despite ongoing efforts, there are deep and unsolved con-
ceptual and theoretical issues regarding the use of compu-
tational modeling and representation of data to advance
the predictive understanding of complex diseases. We
uncovered a few core problems that have not been suffi-
ciently recognized, which must be addressed when trying
to leverage the available and growing amounts of relevant
biological information.
Model selection and parameter uncertainty
Across different application areas, a key question concerns
the handling of model uncertainty. This refers to the fact
that for any biological system there are numerous compet-
ing models. Any discursive model of a biological system
therefore involves uncertainty and incompleteness. Com-
putational model selection has to cope systematically
with the fact that there could be additional relevant inter-
actions and components beyond those that are repre-
sented in the discursive model. For instance, there is often
insufficient experimental determination of kinetic values
for mechanisms contemplated in a verbal model, leading
to serious indetermination of parameters in a computa-
tional model. Hence, biological models, unlike models
describing physical laws, are as a rule highly over-param-
eterized with respect to the available data. This means that
different regions of the parameter space can describe the
available data equally well from a statistical point-of-view.
Because of these interdependencies, interpreting parame-
ter estimates of individual models can be very difficult.
There are good reasons to believe that such interdepend-
encies are unavoidable (and to some degree even desira-
ble, to increase robustness against lesions) in biological
systems [3].
A successful strategy in computational neuroscience has
been to identify minimal models that adequately describe
and predict the biology, but at the potential price of select-
ing a too narrowly focused model. This approach is justi-
fied if adequate knowledge of the underlying mechanisms
involved in a given condition exists. In situations where
the biology is less well-characterized one must consider
and compare several plausible model structures. An alter-
native approach, recently employed within the systems
biology and computational neuroscience fields, is to
search for parameter dimensions (as opposed to individ-
ual parameter sets) that are important for model perform-
ance. This concept of model ensembles represents a
promising approach. The process of characterizing param-
eter values is applied to each model structure and the
resulting ensemble is the collection of model structures
and their associated probabilistic parameter distributions.
Stochastic search of parameter space using a variety of
techniques (e.g. Markov chain Monte Carlo-based) seems
to be state of the art. Multi-start convex optimizations or
particle swarm optimization (PSO) algorithms locate a
potentially large number of local minima of a user-
defined, biologically relevant objective functions. How-
ever, they do not offer assurance of adequate coverage of
parameter space, nor do they have the asymptotic prop-
erty of resulting in a probability density function in
parameter space. It is not yet clear under what conditions
an optimization is most useful. Furthermore, there are no
clear ways to combine selected models to create a consen-
sus ensemble used to formulate predictions: choosing the
"best" structure or weighing competing structures based
on their relative fitness. Model-guided experimental
design appears a promising avenue for clarifying model
structure.
Model selection is therefore important to prevent over-fit-
ting and to distinguish between competing explanations.
Bayesian model selection is utilized in computational
neuroimaging [4] and may also prove useful in systems
biology. There is also a bias towards mechanistic and
molecular models in systems biology. Models should not
only be mechanistic, but also allow for experimental vali-
dation of the mechanisms they propose. This means that
their components should be at a level of description that
allows for the design and/or inclusion of experimental
perturbations using current experimental techniques.
More generally, a mechanistic model is not very helpful
unless there are experimental means to assess its predic-
tive validity (over and beyond its face validity and con-
struct validity; these different types of validity are not
always distinguished, although the distinction is very
important).Page 2 of 3
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The second major theme concerned the development of
hierarchical models, spanning several scales of biological
organization from intracellular molecular networks and
cell-to-cell interactions to interacting tissues and organs of
the whole body.
Much attention was devoted to organ-level models or dis-
eases (e.g., multiple sclerosis, allergic rhinitis and sepsis),
and on the Virtual Physiological Human Project in partic-
ular. Methodologies, like co-simulation which allows for
parallel simulation at different time-scales in different
modules, and modeling environments for integrative
models including different types of equations (ODEs,
PDEs, SDEs etc) were discussed and evaluated. It appears
that the systems biology community focuses on intracel-
lular networks whereas computational neuroscience
emphasizes top-down modeling. Presentations on schizo-
phrenia and nicotine addiction used very simple, top-
down models to explain complex phenomena and offered
useful predictions. By characterizing systems properties,
behavior constraints can propagate to lower scales and
may reduce the number of solutions consistent with
experimental observations. This potential gain has not
been sufficiently exploited when trying to model large-
scale high-throughput data. It must also be recognized
that top-down models of insufficient richness may exces-
sively constrain model space and lose predictive ability.
There is a lack of theory for how to integrate model selec-
tion with constraint propagation across several layers of
biological organization. Development of such a theory
could be useful in modeling complex diseases even when
only sparse data is available. One useful practical first
approximation is the notion of disease networks – i.e. net-
work representations of shared attributes among different
diseases and their (potential) molecular underpinnings.
This approach may provide both bottom-up and top-
down constraints for understanding complex diseases,
enabling a question-driven middle-out approach advo-
cated by Sydney Brenner, Denis Noble and others. There
are multiple well-known examples for these, including
obesity-diabetes, Gaucher disease-Parkinson disease, etc.
At the same time, alteration of the physiome by a given
disease can also lower the chance of developing another
disease, e.g. sickle cell disease. (Hgb S) and malaria infec-
tion. Agent-based approaches also offer the possibility of
multi-scale synthesis by providing a modular framework
for dynamic knowledge representation.
Scientific cultures and the future
During the discussions at the workshop, striking differ-
ences in the scientific "culture" of sub-disciplines of theo-
retical biology were observed. This difference was most
noticeable with regard to different model building
approaches in computational systems biology and com-
putational neuroscience. In the former, much attention is
given to formal methods of model selection and data-
driven model construction. In contrast, in computational
neuroscience (with the notable exception of computa-
tional neuroimaging), formal model selection methods
are almost completely absent. The historical roots of such
differences between the two sub-disciplines have recently
been reviewed [5].
In summary, high priorities for the future of complex dis-
ease modeling are to make progress on model selection
and hierarchical modeling. There is a need for a forum
(ESF network and/or intercontinental efforts) where con-
trol theory, physics and applied mathematics can stimu-
late method development across different areas of
computational biology. Advances in biosystems theory
can nurture current modeling efforts and therefore be
more clinically useful. The study of complex diseases chal-
lenges researchers with unexpected findings and ques-
tions not previously envisioned when studying only basic
biological process. Towards that end, we believe that stud-
ying groups of patients with common patterns of disease
is a useful concept and is a more tractable target in the
short term than truly understanding individualized
dynamics.
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